Cancer `wonderdrug' passes first test

A potential cancer wonder drug that may be able to tackle a host of different diseases has passed its first clinical test, researchers said on Friday. Preliminary results from an early patient trial indicate that the drug is hitting its targets. Scientists hope the drug, known as 17AAG, can be used to attack cancer cells on numerous fronts.The drug targets a so-called "chaperone" molecule called Hsp90 that helps maintain the structure and function of a wide range of proteins. Some of these are vital for the growth of cancers. By deactivating Hsp90, the drug simultaneously sabotages numerous other molecules critical to cancer. As a result, cancer cells stop growing and die.

Cancer `wonderdrug' passes first test | HEALTH | NEWS |

No comments:

Blog Archive